Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke Post Hoc Analysis From the LEADER Trial Article

Industry Collaboration International Collaboration

cited authors

  • Verma, Subodh; Poulter, Neil R.; Bhatt, Deepak L.; Bain, Stephen C.; Buse, John B.; Leiter, Lawrence A.; Nauck, Michael A.; Pratley, Richard E.; Zinman, Bernard; Orsted, David D.; Fries, Tea Monk; Rasmussen, Soren; Marso, Steven P.; LEADER Trial Investigators

authors

Publication Date

  • December 18, 2018

webpage

published in

category

keywords

  • cardiovascular system
  • diabetes mellitus
  • glucagon-like peptide-1
  • liraglutide
  • randomized controlled trial as topic
  • type 2

start page

  • 2884

end page

  • 2894

volume

  • 138

issue

  • 25